Results 181 to 190 of about 35,022 (298)

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial. [PDF]

Eur J Heart Fail, 2023
Chatur S, Claggett BL, Vardeny O, Jering K, Desai AS, Pfeffer MA, Lefkowitz M, McMurray JJV, Solomon SD, Vaduganathan M.   +9 more
europepmc   +1 more source

Inappropriate use of loop diuretics in elderly patients [PDF]

, 2000
Jennifer Kelly
openalex   +1 more source

Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1105-1115, February 2026.
Abstract Background Albuminuria is associated with an increased risk of cardiovascular and kidney events. Sodium glucose co‐transporter 2 inhibitors (SGLT2i) reduce albuminuria and improve kidney outcomes in patients with albuminuric chronic kidney disease (CKD).
João Pedro Ferreira, Pedro Marques, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Abhinav Sharma, Francisco Vasques‐Nóvoa, Luís Mendonça, João Sérgio Neves, Milton Packer, Faiez Zannad   +10 more
wiley   +1 more source

Loop Diuretic Therapy in Severe Aortic Stenosis: Marker or Mediator of Adverse Outcomes? [PDF]

Clin Cardiol
Miyazawa M, Imamura T.
europepmc   +1 more source

Hypertension and its complications in a young man with autoimmune disease [PDF]

, 2017
Basile, Jan N., Batlle, Daniel C., Dhaun, Neeraj, Dominiczak, Anna F., Elijovich, Fernando, Jennings, Garry L.R., Laffer, Cheryl L., Miller-Hodges, Eve, Oliveras, Anna, Oparil, Suzanne   +9 more
core   +1 more source

Executive Summary of the 2024 Philippine Clinical Practice Guidelines on the Diagnosis and Management of Acute Severe Blood Pressure Elevation

The Journal of Clinical Hypertension, Volume 28, Issue 2, February 2026.
ABSTRACT A recent survey in the Philippines, PRESYON‐4, showed increasing prevalence of hypertension from 22% in the 1990s to 37% in 2021, of which only 52% were aware of their diagnosis. While rates of treatment and adherence were 68% and 86%, respectively, the rate of BP control was low at 37%. Furthermore, there remained a high degree of unawareness
Deborah Ignacia D. Ona, Felix Eduardo Punzalan, Raymond V. Oliva, Ma. Sergia Fatima Sucaldito, Noel Espallardo, Richard Santos, Hannah Almenario, Karl Murillo, Valentin Dones III, Elmer Jasper Llanes, Lourdes Ella Santos, Maria Cristina San Jose, Alyssa Samantha Fusingan‐Peralta, Rommel Bataclan, Maria Katrina Mata, Pauline Convocar, Aurelia Leus, Gilbert Vilela   +17 more
wiley   +1 more source

An Analysis of Initial Loop Diuretic Dosing Strategies and Its Association with Time to Decongestion. [PDF]

J Pharm Technol
Taylor G, Starr J, Pinner N.
europepmc   +1 more source

Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators

Pacing and Clinical Electrophysiology, Volume 49, Issue 2, Page 71-81, February 2026.
ABSTRACT Background Implantable cardioverter defibrillator (ICD) therapy can prevent sudden cardiac death, but poses a risk of inappropriate device therapy (IDT), which is linked to worse outcomes and reduced quality of life. On the other hand, ICDs can function as an early warning system for atrial arrhythmias.
Marthe J. Huntelaar, Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Mischa T. Rijnierse, Michiel J. B. Kemme, Cornelis P. Allaart, Vokko P. van Halm   +6 more
wiley   +1 more source

Loop Diuretic Therapy in Severe Aortic Stenosis: Marker of Organ Congestion, Unfavorable Hemodynamics, and Increased Post-Valve Replacement Mortality. [PDF]

Clin Cardiol
Maeder MT, Breuss A, Appert S, Wildermuth S, Haager PK, Rigger J, Chronis J, Schmiady MO, Rickli H, Weber L.   +9 more
europepmc   +1 more source

Loop diuretic management after sacubitril/valsartan initiation in heart failure with preserved ejection fraction: deceptively simple or more than meets the eye? [PDF]

Eur J Heart Fail, 2023
Sinha A, Patel RB.
europepmc   +1 more source